Dare Bioscience, Inc. — Director's Dealing 2024

Jan 29, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2024-01-26

Reporting Person: Haring-Layton MarDee (Chief Accounting Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$2.37	2028-01-16	Common stock (3500)		Direct
Employee Stock Option (right to buy)	$1.01	2028-09-07	Common stock (30000)		Direct
Employee Stock Option (right to buy)	$0.759	2029-01-29	Common stock (35000)		Direct
Employee Stock Option (right to buy)	$1.03	2030-03-06	Common stock (25000)		Direct
Employee Stock Option (right to buy)	$2.59	2031-01-26	Common stock (52000)		Direct
Employee Stock Option (right to buy)	$1.59	2032-01-26	Common stock (42000)		Direct
Employee Stock Option (right to buy)	$1.16	2033-01-24	Common stock (80000)		Direct

Footnotes

F1: This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.